p300 (Histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape
Sumit Isharwal, Michael C. Miller, Cameron Marlow, Danil V. Makarov, Alan W. Partin, Robert W. Veltri
Dive into the research topics of 'p300 (Histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape'. Together they form a unique fingerprint.